aripiprazole has been researched along with Sensitivity and Specificity in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 7 (43.75) | 29.6817 |
| 2010's | 9 (56.25) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gai, Y; Leng, G; Liu, W; Lu, X; Sha, C; Sun, Y; Yang, X | 1 |
| Ambavaram, VB; Gajulapalle, M; Kalluru, GR; Nandigam, V; Vemula, M | 1 |
| Patel, DP; Sanyal, M; Sharma, P; Shrivastav, PS | 1 |
| Carson, W; Correll, CU; Forbes, RA; Mankoski, R; Marcus, R; McQuade, R; Zhao, J | 1 |
| Aitchison, KJ; Heald, AH; Lodhi, RJ; Malik, A; Masand, S; McAllister, VD; O'Keane, V; Sherwood, RA; Shivakumar, K; Young, LC | 1 |
| Akamine, Y; Inoue, Y; Kojima, M; Uno, T; Yasui-Furukori, N | 1 |
| Calabrese, JR; Carlson, BX; Eudicone, JM; Ganocy, S; Kemp, DE; Marcus, RN; McQuade, RD; Owen, R; Tran, QV; Vester-Blokland, E | 1 |
| Brecher, M; Calabrese, JR; Carlson, BX; Edwards, S; Eudicone, JM; Evoniuk, G; Ganocy, SJ; Jansen, W; Kemp, DE; Leon, AC; Minkwitz, M; Pikalov, A; Stassen, HH; Szegedi, A; Tohen, M; Van Willigenburg, AP | 1 |
| Bartlett, MG; Liang, F; Terry, AV | 1 |
| Akiyama, H; Kashiyama, E; Koga, T; Miyamoto, G; Shimokawa, Y | 1 |
| Hirao, Y; Kubo, M; Mizooku, Y; Osumi, T | 1 |
| Basson, BR; Treuer, T | 1 |
| Li, HD; Li, KY; Ren, HY; Wang, F; Zhang, BK; Zhou, YG | 1 |
| Cuffel, BJ; Loebel, AD; Mullins, CD; Naradzay, J; Obeidat, NA | 1 |
| Chiu, HJ; Hu, TM; Huang, HC; Lan, TH; Liu, CH; Tseng, YL; Wu, YC | 1 |
| Brovedani, S; Djebrani, K; Kraoul, L; Lancelin, F; Paubel, P; Piketty, ML; Tabaouti, K | 1 |
1 review(s) available for aripiprazole and Sensitivity and Specificity
| Article | Year |
|---|---|
Predictive value of early improvement in bipolar depression trials: a post-hoc pooled analysis of two 8-week aripiprazole studies.
Topics: Adult; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Double-Blind Method; Drug Resistance; Female; Humans; Linear Models; Logistic Models; Male; Middle Aged; Multicenter Studies as Topic; Piperazines; Predictive Value of Tests; Psychiatric Status Rating Scales; Quinolones; Randomized Controlled Trials as Topic; Remission Induction; Sensitivity and Specificity; Time Factors; Treatment Outcome | 2010 |
2 trial(s) available for aripiprazole and Sensitivity and Specificity
| Article | Year |
|---|---|
Early antipsychotic response to aripiprazole in adolescents with schizophrenia: predictive value for clinical outcomes.
Topics: Adolescent; Antipsychotic Agents; Aripiprazole; Double-Blind Method; Humans; Piperazines; Placebos; Predictive Value of Tests; Psychiatric Status Rating Scales; Quinolones; Schizophrenia; Sensitivity and Specificity; Time Factors; Treatment Outcome | 2013 |
Clinical value of early partial symptomatic improvement in the prediction of response and remission during short-term treatment trials in 3369 subjects with bipolar I or II depression.
Topics: Antidepressive Agents, Second-Generation; Antimanic Agents; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Bipolar Disorder; Dibenzothiazepines; Drug Therapy, Combination; Fluoxetine; Humans; Lamotrigine; Olanzapine; Piperazines; Predictive Value of Tests; Psychiatric Status Rating Scales; Quetiapine Fumarate; Quinolones; Remission Induction; Sensitivity and Specificity; Time Factors; Treatment Outcome; Triazines | 2011 |
13 other study(ies) available for aripiprazole and Sensitivity and Specificity
| Article | Year |
|---|---|
LC-MS/MS method for the determination of the prodrug aripiprazole lauroxil and its three metabolites in plasma and its application to in vitro biotransformation and animal pharmacokinetic studies.
Topics: Animals; Aripiprazole; Biotransformation; Chromatography, Liquid; Linear Models; Male; Prodrugs; Rats, Sprague-Dawley; Reproducibility of Results; Sensitivity and Specificity; Tandem Mass Spectrometry | 2018 |
Liquid chromatography-tandem mass spectrometry method for simultaneous quantification of urapidil and aripiprazole in human plasma and its application to human pharmacokinetic study.
Topics: Acetates; Aripiprazole; Chromatography, Liquid; Drug Stability; Humans; Least-Squares Analysis; Liquid-Liquid Extraction; Male; Piperazines; Quinolones; Reproducibility of Results; Sensitivity and Specificity; Tandem Mass Spectrometry | 2013 |
SPE-UPLC-MS/MS method for sensitive and rapid determination of aripiprazole in human plasma to support a bioequivalence study.
Topics: Aripiprazole; Chromatography, High Pressure Liquid; Humans; Linear Models; Piperazines; Quinolones; Reproducibility of Results; Sensitivity and Specificity; Solid Phase Extraction; Tandem Mass Spectrometry; Therapeutic Equivalency | 2013 |
Changes in biomarkers of bone turnover in an aripiprazole add-on or switching study.
Topics: Adolescent; Adult; Antipsychotic Agents; Aripiprazole; Biomarkers; Bipolar Disorder; Bone Remodeling; Estrogens; Female; Follow-Up Studies; Humans; Male; Middle Aged; PAX5 Transcription Factor; Prolactin; Prospective Studies; Psychotic Disorders; Schizophrenia; Sensitivity and Specificity; Testosterone; Young Adult | 2016 |
A sensitive column-switching HPLC method for aripiprazole and dehydroaripiprazole and its application to human pharmacokinetic studies.
Topics: Adult; Antipsychotic Agents; Aripiprazole; Chromatography, High Pressure Liquid; Female; Humans; Male; Molecular Structure; Piperazines; Quinolones; Reproducibility of Results; Sensitivity and Specificity; Young Adult | 2010 |
Determination of aripiprazole in rat plasma and brain using ultra-performance liquid chromatography/electrospray ionization tandem mass spectrometry.
Topics: Animals; Aripiprazole; Brain Chemistry; Chromatography, High Pressure Liquid; Drug Stability; Linear Models; Male; Piperazines; Quinolones; Rats; Rats, Wistar; Reproducibility of Results; Sensitivity and Specificity; Spectrometry, Mass, Electrospray Ionization; Tandem Mass Spectrometry | 2012 |
High performance liquid chromatographic methods for the determination of aripiprazole with ultraviolet detection in rat plasma and brain: application to the pharmacokinetic study.
Topics: Animals; Antipsychotic Agents; Aripiprazole; Brain Chemistry; Chromatography, High Pressure Liquid; Drug Stability; Freezing; Male; Piperazines; Quinolones; Rats; Rats, Sprague-Dawley; Reproducibility of Results; Sensitivity and Specificity; Spectrophotometry, Ultraviolet | 2005 |
Development and validation of an LC-MS/MS method for the quantitative determination of aripiprazole and its main metabolite, OPC-14857, in human plasma.
Topics: Aripiprazole; Chromatography, Liquid; Drug Stability; Humans; Mass Spectrometry; Piperazines; Quinolones; Reproducibility of Results; Sensitivity and Specificity | 2005 |
Is there a real difference between the first onset of efficacy for atypical antipsychotic monotherapies in acute bipolar mania?
Topics: Acute Disease; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Clinical Trials as Topic; Humans; Outcome Assessment, Health Care; Piperazines; Psychiatric Status Rating Scales; Quinolones; Research Design; Risperidone; Sensitivity and Specificity; Time Factors; Treatment Outcome | 2005 |
Ultra-performance liquid chromatography-tandem mass spectrometry for the determination of atypical antipsychotics and some metabolites in in vitro samples.
Topics: Antipsychotic Agents; Aripiprazole; Chromatography, High Pressure Liquid; Dibenzothiazepines; Indoles; Isoindoles; Piperazines; Quetiapine Fumarate; Quinolones; Reference Standards; Reproducibility of Results; Sensitivity and Specificity; Spectrometry, Mass, Electrospray Ionization; Tandem Mass Spectrometry; Thiazoles | 2007 |
Risk of discontinuation of atypical antipsychotic agents in the treatment of schizophrenia.
Topics: Adolescent; Adult; Antipsychotic Agents; Aripiprazole; Dibenzothiazepines; Female; Follow-Up Studies; Humans; Male; Middle Aged; Patient Readmission; Piperazines; Proportional Hazards Models; Quetiapine Fumarate; Quinolones; Randomized Controlled Trials as Topic; Risk Factors; Risperidone; Schizophrenia; Schizophrenia, Paranoid; Schizophrenic Psychology; Sensitivity and Specificity; Substance Withdrawal Syndrome; Survival Rate; Thiazoles | 2008 |
Detection and quantification of aripiprazole and its metabolite, dehydroaripiprazole, by gas chromatography-mass spectrometry in blood samples of psychiatric patients.
Topics: Antipsychotic Agents; Aripiprazole; Gas Chromatography-Mass Spectrometry; Humans; Mental Disorders; Piperazines; Quinolones; Reference Standards; Sensitivity and Specificity | 2007 |
Development and validation of a high-performance liquid chromatography method using diode array detection for the simultaneous quantification of aripiprazole and dehydro-aripiprazole in human plasma.
Topics: Adolescent; Adult; Aripiprazole; Calibration; Chromatography, High Pressure Liquid; Drug Monitoring; Female; Humans; Male; Middle Aged; Piperazines; Quinolones; Reproducibility of Results; Sensitivity and Specificity; Spectrophotometry, Ultraviolet | 2008 |